Prognostic significance of alterations in KRAS isoforms KRAS-4A/4B andKRASmutations in colorectal carcinoma-Reference-Cited by-同舟云学术

Prognostic significance of alterations in KRAS isoforms KRAS-4A/4B andKRASmutations in colorectal carcinoma

Published:2009-12 Issue:4 Volume:219 Page:435-445
ISSN:0022-3417
Container-title:The Journal of Pathology
language:en
Short-container-title:J. Pathol.

Author:

Abubaker Jehad,Bavi Prashant,Al-Haqawi Wael,Sultana Mehar,Al-Harbi Sayer,Al-Sanea Nasser,Abduljabbar Alaa,Ashari Luai H,Alhomoud Samar,Al-Dayel Fouad,Uddin Shahab,Al-Kuraya Khawla S

Publisher

Wiley

Subject

Pathology and Forensic Medicine

Reference53 articles.

1. Colorectal cancer: a multipathway disease;Jass;Crit Rev Oncogenesis,2006

2. Lessons from hereditary colorectal cancer;Kinzler;Cell,1996

3. Genetic alterations during colorectal-tumor development;Vogelstein;N Engl J Med,1988

4. RAS oncogenes: the first 30 years;Malumbres;Nature Rev,2003

5. Four human ras homologs differ in their abilities to activate Raf-1, induce transformation, and stimulate cell motility;Voice;J Biol Chem,1999

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Phase II, Open-Label, Randomized Trial of Durvalumab With Olaparib or Cediranib in Patients With Mismatch Repair—Proficient Colorectal or Pancreatic Cancer;Clinical Colorectal Cancer;2024-09

2. KRAS Mutation Subtypes and Their Association with Other Driver Mutations in Oncogenic Pathways;Cells;2024-07-19

3. Mapping alternative splicing events in colorectal cancer;Discover Oncology;2024-07-15

4. KRAS4A and KRAS4B in liquid biopsy of metastatic lung adenocarcinoma patients treated with Pembrolizumab or chemotherapy plus Pembrolizumab;Scientific Reports;2023-11-29

5. Risk factor analysis for anti-epidermal growth factor receptor monoclonal antibody–induced skin toxicities in real-world metastatic colorectal cancer treatment;Supportive Care in Cancer;2023-08